Sun Pharma is a global pharmaceutical company with operations in over 100 countries, including our ophthalmic division, where we are committed to pursuing life-changing technology in eye care. Discover a brighter future in eye care. Learn more at www.SunPharma.com | Sun Pharma is the 4th largest specialty generic pharmaceutical company in the world, providing high-quality, affordable medicines in over 150 countries. Our mission is to enhance people’s lives with innovative and quality generic, branded, and over-the-counter medicines, providing exceptional value in our communities. In the US, Sun Pharma is focused on helping patients in Dermatology, Oncology, Ophthalmology, and Neurology.
Rayner Surgical Inc.
With over 75 years of innovation, Rayner continues to set new standards in ophthalmology, delivering precision-driven solutions that support surgeons and enhance patient outcomes. Rayner’s portfolio spans IOLs, ophthalmic pharmaceuticals, equipment, and digital solutions, meeting the evolving needs of surgeons and their patients.
OSRX Inc.
OSRX is an FDA-registered 503B outsourcing facility committed to transforming ophthalmic care through quality compounded solutions. The Missoula, MT-based company is on a mission to redefine the landscape of the corrective eye care market with a focus on simplicity, affordability, and patient-centric care.
Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across development, treatment, and outcomes. OTX-TKI (also known as AXPAXLI™), Ocular’s investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX™ proprietary bioresorbable hydrogel-based technology. It is currently in Phase 3 clinical trials to advance wet age-related macular degeneration (AMD) and diabetic retinopathy (DR) treatment, aiming to improve long-term outcomes while reducing the frequency of injections. | Ocular Therapeutix, Inc. is a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions.
iPothecary
iPothecary is a physician-guided platform that enables ophthalmology and optometry practices to recommend and deliver trusted eye care products directly to patients. By connecting patients with curated, doctor-recommended treatments, iPothecary helps practices extend care beyond the exam room, improve treatment adherence, and simplify access to professional-grade ocular therapies.
Cloudbreak Pharma, Inc.
Cloudbreak Pharma is a clinical-stage company pioneering Multi-Kinase Inhibitors (MKIs) for eye diseases. Our lead candidate, CBT-001, is in mid-Phase 3 for pterygium, with CBT-004 entering Phase 3 for pinguecula—potentially the first FDA-approved treatments for these large, underserved markets, supported by proven clinical results and an experienced ophthalmology team.
Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for people all over the world – from birth through every phase of life. | Bausch + Lomb is a global eye health organization with core businesses in over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry.
Aurolab
Aurolab, based in southern part of India, is an integral part of the Aravind Eye Care System. It manufactures a wide range of high quality ophthalmic consumables such as intraocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments.